Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
3.470
+0.090 (2.66%)
Nov 22, 2024, 4:00 PM EST - Market closed
Personalis Employees
As of December 31, 2023, Personalis had 225 total employees, including 223 full-time and 2 part-time employees. The number of employees decreased by 174 or -43.61% compared to the previous year.
Employees
225
Change (1Y)
-174
Growth (1Y)
-43.61%
Revenue / Employee
$388,840
Profits / Employee
-$406,413
Market Cap
245.15M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accuray | 987 |
InfuSystem Holdings | 516 |
ADC Therapeutics | 274 |
Editas Medicine | 265 |
Sight Sciences | 214 |
Molecular Partners AG | 168 |
Enanta Pharmaceuticals | 145 |
Senseonics Holdings | 132 |
PSNL News
- 2 days ago - Personalis to Participate at Upcoming Investor Conferences - Business Wire
- 16 days ago - Personalis, Inc. (PSNL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Personalis Reports Third Quarter 2024 Financial Results - Business Wire
- 17 days ago - Personalis to Present at the Stifel 2024 Healthcare Conference - Business Wire
- 4 weeks ago - Personalis to Announce Third Quarter 2024 Financial Results - Business Wire
- 2 months ago - ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test - Business Wire
- 3 months ago - Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Personalis: Resetting My Strategy Following The Q2 Beat - Seeking Alpha